Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2025JMIR DiabetesOpen Access

Assessing the Clinical Feasibility of the DiaFocus System for Integrated Personalized Management of Type 2 Diabetes: 6-Month Pilot Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Authors

NLNanna LindPBPer BækgaardJBJakob E. Bardram

Discussion

Loading...

Member takes

Overview

Pilot cohort study tested the DiaFocus mobile health system for personalized diabetes management, indicating its acceptability and need for optimization.

Key Points

  • The DiaFocus system supports diabetes management through personalized monitoring and communication, showing initial feasibility.
  • Out of 17 participants with T2D, 90% found the system easy to use, but clinical outcomes showed no significant changes.
  • Participants reported preferences for focus areas like blood glucose and exercise, emphasizing the need for shared decision-making.
  • Despite positive feedback on acceptability, the app's functionality requires further optimization for improved clinical use.

Cite This Study

Lind et al. (2025) studied this question.

synapsesocial.com/papers/68af7b247567bf4f94ff3102https://doi.org/10.2196/63894
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Protocol for the Digital, Individualized, and Collaborative Treatment of Type 2 Diabetes in General Practice Based on Decision Aid (DICTA)—A Randomized Controlled Trial2025
  2. 2Experiences of People With Poorly Controlled Type 2 Diabetes Using Telemonitoring: Qualitative Study Embedded in a Feasibility Trial2026
  3. 3Caregiver experiences of an integrative patient-centered digital health application for pediatric type 1 diabetes care: findings from a pilot clinical trial2025
  4. 4A phased online support program improves self-efficacy and reduces distress in type 2 diabetes patients using mixed methods design2025
  5. 52783-LB: The Diabetes Telemedicine Mediterranean Diet (DiaTeleMed) Study: A Six-Month, Fully Remote, Randomized Clinical Trial Evaluating Personalized Dietary Management in Individuals with Type 2 Diabetes2026